Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis

Given the availability and efficacy of the mobilizing agent plerixafor in augmenting hematopoietic progenitor cell mobilization with granulocyte colony-stimulating factor (G-CSF), there is a strong case for comparing the cost-effectiveness of mobilization with G-CSF + cyclophosphamide versus G-CSF a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzaro, Carlo, Castagna, Luca, Lanza, Francesco, Laszlo, Daniele, Milone, Giuseppe, Pierelli, Luca, Saccardi, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338551/
https://www.ncbi.nlm.nih.gov/pubmed/33753907
http://dx.doi.org/10.1038/s41409-021-01251-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338551/
https://www.ncbi.nlm.nih.gov/pubmed/33753907
http://dx.doi.org/10.1038/s41409-021-01251-8

Ejemplares similares